Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	10	26	30	53	50	42
Market Cap Growth	-52.10%	-15.67%	-42.91%	6.75%	18.99%	48.31%
Enterprise Value	-6	3	-12	-18	35	31
PE Ratio	-	-0.86	-1.04	-3.34	-2.87	-3.17
PB Ratio	0.46	0.98	0.58	0.67	2.80	2.69
P/FCF Ratio	-0.53	-1.06	-1.10	-2.80	-2.74	-2.43
P/OCF Ratio	-0.53	-1.06	-1.10	-2.80	-2.80	-2.43
EV/EBITDA Ratio	0.12	-0.08	0.43	1.12	-2.03	-2.37
EV/EBIT Ratio	0.12	-0.08	0.43	1.11	-2.00	-2.34
EV/FCF Ratio	0.13	-0.10	0.45	0.93	-1.92	-1.82
Debt / Equity Ratio	0.02	0.02	0.01	0.00	0.01	0.02
Debt / EBITDA Ratio	-0.02	-0.02	-0.01	0.00	-0.01	-0.02
Debt / FCF Ratio	-0.02	-0.02	-0.01	0.00	-0.01	-0.02
Quick Ratio	3.11	3.46	8.95	19.58	5.20	3.01
Current Ratio	3.51	3.86	9.46	20.02	5.89	3.78
Return on Equity (ROE)	-87.20%	-80.90%	-46.50%	-19.10%	-109.90%	-74.10%
Return on Assets (ROA)	-68.90%	-67.70%	-42.20%	-17.40%	-61.40%	-48.60%
Return on Capital (ROIC)	-126.85%	-111.62%	-58.33%	-29.05%	-110.17%	-110.58%
Earnings Yield	-268.93%	-116.33%	-95.65%	-29.90%	-34.86%	-31.56%
FCF Yield	-249.89%	-94.67%	-91.30%	-35.69%	-36.44%	-41.22%
Buyback Yield / Dilution	-28.67%	-3.60%	-6.43%	-172.97%	-45.07%	-57.20%
Total Shareholder Return	-28.67%	-3.60%	-6.43%	-172.97%	-45.07%	-57.20%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).